BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 26471380)

  • 1. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.
    Klein P; Schiemann J; Sperling MR; Whitesides J; Liang W; Stalvey T; Brandt C; Kwan P
    Epilepsia; 2015 Dec; 56(12):1890-8. PubMed ID: 26471380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
    Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.
    Van Paesschen W; Hirsch E; Johnson M; Falter U; von Rosenstiel P
    Epilepsia; 2013 Jan; 54(1):89-97. PubMed ID: 22813235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.
    Ben-Menachem E; Mameniškienė R; Quarato PP; Klein P; Gamage J; Schiemann J; Johnson ME; Whitesides J; McDonough B; Eckhardt K
    Neurology; 2016 Jul; 87(3):314-23. PubMed ID: 27335114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with uncontrolled focal-onset seizures: A phase III randomized, double-blind, placebo-controlled trial.
    Inoue Y; Tiamkao S; Zhou D; Cabral-Lim L; Lim KS; Lim SH; Tsai JJ; Moseley B; Wang L; Sun W; Hayakawa Y; Sasamoto H; Sano T; McClung C; Bass A
    Epilepsia Open; 2024 Jun; 9(3):1007-1020. PubMed ID: 38576178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis.
    Benbadis S; Klein P; Schiemann J; Diaz A; Elmoufti S; Whitesides J
    Epilepsy Behav; 2018 Mar; 80():129-134. PubMed ID: 29414542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: Post-hoc analysis of a randomized, placebo-controlled trial.
    Klein P; McLachlan R; Foris K; Nondonfaz X; Elmoufti S; Dimova S; Brandt C
    Epilepsy Res; 2020 Nov; 167():106369. PubMed ID: 32717713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial.
    French JA; Costantini C; Brodsky A; von Rosenstiel P;
    Neurology; 2010 Aug; 75(6):519-25. PubMed ID: 20592253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies.
    Brodie MJ; Whitesides J; Schiemann J; D'Souza J; Johnson ME
    Epilepsy Res; 2016 Nov; 127():114-118. PubMed ID: 27589414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures.
    Toledo M; Whitesides J; Schiemann J; Johnson ME; Eckhardt K; McDonough B; Borghs S; Kwan P
    Epilepsia; 2016 Jul; 57(7):1139-51. PubMed ID: 27265725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies.
    Moseley BD; Sperling MR; Asadi-Pooya AA; Diaz A; Elmouft S; Schiemann J; Whitesides J
    Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion to brivaracetam monotherapy for the treatment of patients with focal seizures: Two double-blind, randomized, multicenter, historical control, Phase III studies.
    Arnold S; Badalamenti V; Diaz A; Gasalla T; McShea C; Whitesides J; Fakhoury T
    Epilepsy Res; 2018 Mar; 141():73-82. PubMed ID: 29486396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures.
    Meador KJ; Dimova S; Bourikas D; Elmoufti S; Floricel F; Laloyaux C; Moseley B; Nondonfaz X; Klein P
    Epilepsy Behav; 2024 Jul; 156():109844. PubMed ID: 38788664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of brivaracetam at different doses for partial-onset epilepsy: a meta-analysis of placebo-controlled studies.
    Tian X; Yuan M; Zhou Q; Wang X
    Expert Opin Pharmacother; 2015; 16(12):1755-67. PubMed ID: 26165169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials.
    Ma J; Huang S; You C
    Epilepsy Res; 2015 Aug; 114():59-65. PubMed ID: 26088886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
    Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
    Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies.
    Kälviäinen R; Genton P; Andermann E; Andermann F; Magaudda A; Frucht SJ; Schlit AF; Gerard D; de la Loge C; von Rosenstiel P
    Epilepsia; 2016 Feb; 57(2):210-21. PubMed ID: 26666500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis.
    Lee SK; Heo K; Kim SE; Lee SA; Elmoufti S; Laloyaux C; Hur B
    Adv Ther; 2021 Jul; 38(7):4082-4099. PubMed ID: 34155568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.